Invention Grant
- Patent Title: Use of adenovirus and nucleic acids coding therefor
-
Application No.: US15452470Application Date: 2017-03-07
-
Publication No.: US10538744B2Publication Date: 2020-01-21
- Inventor: Per Sonne Holm
- Applicant: Per Sonne Holm
- Agency: Casimir Jones, S.C.
- Agent Peter J. Schlueter
- Priority: DE10223534 20020527; DE10225400 20020607; DE10248039 20021015; DE10322530 20030519
- Main IPC: C12N7/00
- IPC: C12N7/00 ; C07K14/005 ; C12N15/86 ; A61K35/761 ; A61K35/763 ; A61K48/00 ; A61K38/00
Abstract:
This invention relates to the use of an adenovirus to treat cancer, for example. The adenovirus may be replication deficient in cells that lack Y box binding protein. The adenovirus may encode an oncogene or an oncogene product, which may transactivate at least one viral gene.
Public/Granted literature
- US20180002674A1 USE OF ADENOVIRUS AND NUCLEIC ACIDS CODING THEREFOR Public/Granted day:2018-01-04
Information query
